funkykoh personal page - To The Moon

funkykoh

funkykoh

No personal profile

46Follow

3Followers

0Topic

0Badge

2021-06-24

Yay finally got a T!

2021-06-23

2021-06-23

Hmmm

Here's What Happened to NVIDIA During the Last Crypto Crash

2021-06-22

Yes

Goldman Sees Another $500 Billion Being Plowed Into U.S. Stocks

2021-06-22

Good

Sorry, the original content has been removed

2021-06-21

Wow

Orphazyme rose more than 6% in premarket trading

2021-06-17

Oh

Toplines Before US Market Open on Wednesday

2021-06-13

But the risk is small and may have other triggering factors

COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart

2021-05-11

All crashing

Sorry, the original content has been removed

2021-05-11

To sell or to keep?

Sorry, the original content has been removed

2021-04-20

Okay

Snap Earnings: Here's What to Watch

2021-04-20

Hmmm

Should You Buy Apple Stock Before Next Apple Event?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3582025009793897,"uuid":"3582025009793897","gmtCreate":1618931612552,"gmtModify":1618973100510,"name":"funkykoh","pinyin":"funkykoh","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":46,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":121778542,"gmtCreate":1624494131986,"gmtModify":1703838188780,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yay finally got a T!&nbsp;","listText":"Yay finally got a T!&nbsp;","text":"Yay finally got a T!","images":[{"img":"https://static.tigerbbs.com/41e1cda6782c1b9e8393b0621a66683c","width":"1080","height":"2685"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121778542","isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121638689,"gmtCreate":1624461089041,"gmtModify":1703837534144,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SQ\">$Square(SQ)$</a>?","listText":"<a href=\"https://laohu8.com/S/SQ\">$Square(SQ)$</a>?","text":"$Square(SQ)$?","images":[{"img":"https://static.tigerbbs.com/ce7e770b0eca75081665081998ce062d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121638689","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121108782,"gmtCreate":1624455857946,"gmtModify":1703837223403,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121108782","repostId":"2145283099","repostType":4,"repost":{"id":"2145283099","pubTimestamp":1624452600,"share":"https://www.laohu8.com/m/news/2145283099?lang=&edition=full","pubTime":"2021-06-23 20:50","market":"us","language":"en","title":"Here's What Happened to NVIDIA During the Last Crypto Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2145283099","media":"Motley Fool","summary":"Sales fell off a cliff, and so did the stock price.","content":"<p>It's starting to look like the cryptocurrency bubble is bursting. As of this writing, the price of <b>Bitcoin</b> (CRYPTO:BTC) has dipped below $30,000, erasing its gains for the year. Bitcoin is now down more than 50% from its all-time high.</p>\n<p>Other cryptocurrencies are doing even worse. <b>Ethereum</b> (CRYPTO:ETH) is down nearly 60% from its high, and joke cryptocurrency <b>Dogecoin</b> (CRYPTO:DOGE) has crashed 75%.</p>\n<p>Graphics chip developer <b>NVIDIA</b> (NASDAQ:NVDA) has been <a href=\"https://laohu8.com/S/AONE\">one</a> beneficiary of the crypto bubble. The company's graphics cards are useful for mining certain cryptocurrencies. This fact has boosted demand for graphics cards, contributing to shortages and high prices.</p>\n<p><img src=\"https://static.tigerbbs.com/9eae70fe3111cdeb0fe2fe15c5e5fcf3\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p>NVIDIA sells some models specifically aimed at cryptocurrency miners, but miners are also buying plenty of standard graphics cards through the same channels used by PC gamers. This makes it difficult to tell how much of NVIDIA's gaming revenue is a side-effect of the cryptocurrency bubble. NVIDIA's gaming revenue more than doubled year-over-year to $2.76 billion in its latest quarter.</p>\n<p>What happens if crypto prices continue to crash? It wasn't pretty for NVIDIA last time around.</p>\n<h3>From shortage to supply glut</h3>\n<p>The price of bitcoin and other cryptocurrencies soared throughout 2017 and early 2018. Miners snapped up graphics cards, leading to shortages and high prices. Sound familiar?</p>\n<p>NVIDIA's quarterly gaming revenue held steady at around $1.8 billion through the third quarter of fiscal 2019, which ended in October of 2018. Then it fell off a cliff as interest in cryptocurrency waned. Gaming revenue crashed below $1 billion in the fiscal fourth quarter of that year.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F631439%2Fnvidia-gaming-revenue-crypto.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"501\" referrerpolicy=\"no-referrer\"></p>\n<p>Chart by author. Data source: NVIDIA.</p>\n<p>The crypto crash of 2018 led to bloated channel inventories of graphics cards, which reduced NVIDIA's sales dramatically. Gaming revenue was depressed for about three quarters before bouncing back.</p>\n<p>\"Crypto mining demand and its after effects have distorted the quarter-to-quarter trends in the gaming business and obscured its underlying trend line,\" NVIDIA CFO Colette Kress said during the Q4 2019 earnings call.</p>\n<p>Kress continued: \"...with the benefit of hindsight, we shipped a higher amount of desktop gaming products relative to where end demand turned out to be.\"</p>\n<p>What's happening now is a turbocharged version of what happened in 2018. The total value of the cryptocurrency market at the peak this time around was far higher than in 2018, topping $2 trillion in April.</p>\n<p>Actual shipments of graphics cards were up 24.4% in the first quarter on a year-over-year basis, according to Jon Peddie Research. The total value of those cards soared 370% thanks to inflated prices. Some of this demand has undoubtedly been driven by the pandemic, but a big chunk is tied to the fortunes of the cryptocurrency market.</p>\n<p>Just like NVIDIA's gaming revenue, NVIDIA stock was hit hard by the last crypto crash. Shares tanked in the final three months of 2018 as the extent of NVIDIA's dependence on crypto miners demand became clear.</p>\n<p><img src=\"https://static.tigerbbs.com/872169a76058d1b9cde031da052b3211\" tg-width=\"720\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n<p>NVDA data by YCharts</p>\n<p>NVIDIA stock has once again surged amid a cryptocurrency boom and shortages of graphics cards. The company is now worth about $460 billion, about triple its peak value during the last cryptocurrency bubble. NVIDIA has made strides outside of gaming since then, particularly in the data center. But a big drop in revenue is possible, and perhaps likely, if crypto prices keep tumbling.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's What Happened to NVIDIA During the Last Crypto Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's What Happened to NVIDIA During the Last Crypto Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 20:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/23/nvidia-stock-crypto-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's starting to look like the cryptocurrency bubble is bursting. As of this writing, the price of Bitcoin (CRYPTO:BTC) has dipped below $30,000, erasing its gains for the year. Bitcoin is now down ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/23/nvidia-stock-crypto-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2021/06/23/nvidia-stock-crypto-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145283099","content_text":"It's starting to look like the cryptocurrency bubble is bursting. As of this writing, the price of Bitcoin (CRYPTO:BTC) has dipped below $30,000, erasing its gains for the year. Bitcoin is now down more than 50% from its all-time high.\nOther cryptocurrencies are doing even worse. Ethereum (CRYPTO:ETH) is down nearly 60% from its high, and joke cryptocurrency Dogecoin (CRYPTO:DOGE) has crashed 75%.\nGraphics chip developer NVIDIA (NASDAQ:NVDA) has been one beneficiary of the crypto bubble. The company's graphics cards are useful for mining certain cryptocurrencies. This fact has boosted demand for graphics cards, contributing to shortages and high prices.\n\nImage source: Getty Images.\nNVIDIA sells some models specifically aimed at cryptocurrency miners, but miners are also buying plenty of standard graphics cards through the same channels used by PC gamers. This makes it difficult to tell how much of NVIDIA's gaming revenue is a side-effect of the cryptocurrency bubble. NVIDIA's gaming revenue more than doubled year-over-year to $2.76 billion in its latest quarter.\nWhat happens if crypto prices continue to crash? It wasn't pretty for NVIDIA last time around.\nFrom shortage to supply glut\nThe price of bitcoin and other cryptocurrencies soared throughout 2017 and early 2018. Miners snapped up graphics cards, leading to shortages and high prices. Sound familiar?\nNVIDIA's quarterly gaming revenue held steady at around $1.8 billion through the third quarter of fiscal 2019, which ended in October of 2018. Then it fell off a cliff as interest in cryptocurrency waned. Gaming revenue crashed below $1 billion in the fiscal fourth quarter of that year.\n\nChart by author. Data source: NVIDIA.\nThe crypto crash of 2018 led to bloated channel inventories of graphics cards, which reduced NVIDIA's sales dramatically. Gaming revenue was depressed for about three quarters before bouncing back.\n\"Crypto mining demand and its after effects have distorted the quarter-to-quarter trends in the gaming business and obscured its underlying trend line,\" NVIDIA CFO Colette Kress said during the Q4 2019 earnings call.\nKress continued: \"...with the benefit of hindsight, we shipped a higher amount of desktop gaming products relative to where end demand turned out to be.\"\nWhat's happening now is a turbocharged version of what happened in 2018. The total value of the cryptocurrency market at the peak this time around was far higher than in 2018, topping $2 trillion in April.\nActual shipments of graphics cards were up 24.4% in the first quarter on a year-over-year basis, according to Jon Peddie Research. The total value of those cards soared 370% thanks to inflated prices. Some of this demand has undoubtedly been driven by the pandemic, but a big chunk is tied to the fortunes of the cryptocurrency market.\nJust like NVIDIA's gaming revenue, NVIDIA stock was hit hard by the last crypto crash. Shares tanked in the final three months of 2018 as the extent of NVIDIA's dependence on crypto miners demand became clear.\n\nNVDA data by YCharts\nNVIDIA stock has once again surged amid a cryptocurrency boom and shortages of graphics cards. The company is now worth about $460 billion, about triple its peak value during the last cryptocurrency bubble. NVIDIA has made strides outside of gaming since then, particularly in the data center. But a big drop in revenue is possible, and perhaps likely, if crypto prices keep tumbling.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120477113,"gmtCreate":1624335432832,"gmtModify":1703833814833,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120477113","repostId":"1134679198","repostType":4,"repost":{"id":"1134679198","pubTimestamp":1624332186,"share":"https://www.laohu8.com/m/news/1134679198?lang=&edition=full","pubTime":"2021-06-22 11:23","market":"us","language":"en","title":"Goldman Sees Another $500 Billion Being Plowed Into U.S. Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1134679198","media":"finance.yahoo","summary":"(Bloomberg) -- Households and corporations will buy an additional $500 billion of U.S. stocks throug","content":"<p>(Bloomberg) -- Households and corporations will buy an additional $500 billion of U.S. stocks through the year-end, even as equities trade near record highs, according to Goldman Sachs Group Inc.</p>\n<p>The splurge is set to happen amid a record $5.5 trillion of cash that’s sitting idle, having swollen through the pandemic, Goldman strategists led by David J. Kostin wrote in a note. They expect corporations to be the biggest source of equity demand for the rest of 2021, with buybacks set to accelerate and issuance poised to slow from peak first-quarter levels.</p>\n<p>In the first quarter, households bought a net $172 billion of equities, Goldman said, with demand set to be boosted further by swollen levels of cash and growing market participation by retail investors that has led to the wild swings seen in so-called meme stocks this year.</p>\n<p>Investor appetite for equities shows no sign of abating, even as U.S. and European stocks trade close to record highs and as U.S. Federal Reserve officials signal they’re getting ready to scale back stimulus.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sees Another $500 Billion Being Plowed Into U.S. Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sees Another $500 Billion Being Plowed Into U.S. Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 11:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/goldman-sees-another-500-billion-120837569.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Households and corporations will buy an additional $500 billion of U.S. stocks through the year-end, even as equities trade near record highs, according to Goldman Sachs Group Inc.\nThe ...</p>\n\n<a href=\"https://finance.yahoo.com/news/goldman-sees-another-500-billion-120837569.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://finance.yahoo.com/news/goldman-sees-another-500-billion-120837569.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134679198","content_text":"(Bloomberg) -- Households and corporations will buy an additional $500 billion of U.S. stocks through the year-end, even as equities trade near record highs, according to Goldman Sachs Group Inc.\nThe splurge is set to happen amid a record $5.5 trillion of cash that’s sitting idle, having swollen through the pandemic, Goldman strategists led by David J. Kostin wrote in a note. They expect corporations to be the biggest source of equity demand for the rest of 2021, with buybacks set to accelerate and issuance poised to slow from peak first-quarter levels.\nIn the first quarter, households bought a net $172 billion of equities, Goldman said, with demand set to be boosted further by swollen levels of cash and growing market participation by retail investors that has led to the wild swings seen in so-called meme stocks this year.\nInvestor appetite for equities shows no sign of abating, even as U.S. and European stocks trade close to record highs and as U.S. Federal Reserve officials signal they’re getting ready to scale back stimulus.","news_type":1},"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3579764463709225","authorId":"3579764463709225","name":"AhKeong","avatar":"https://community-static.tradeup.com/news/b20c0291da6c54ef8f3c421a4ed45c27","crmLevel":2,"crmLevelSwitch":1},"content":"that's Cool. comment n like","text":"that's Cool. comment n like","html":"that's Cool. comment n like"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120916632,"gmtCreate":1624291687426,"gmtModify":1703832754617,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120916632","repostId":"1127414335","repostType":4,"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167466964,"gmtCreate":1624282663258,"gmtModify":1703832357074,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167466964","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading ","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1},"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163343016,"gmtCreate":1623860473335,"gmtModify":1703821842138,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/163343016","repostId":"1185341836","repostType":4,"repost":{"id":"1185341836","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623845207,"share":"https://www.laohu8.com/m/news/1185341836?lang=&edition=full","pubTime":"2021-06-16 20:06","market":"hk","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1185341836","media":"Tiger Newspress","summary":"U.S. stock index futures were mostly flat on Wednesday ahead of the Federal Reserve's update on mone","content":"<p>U.S. stock index futures were mostly flat on Wednesday ahead of the&nbsp;Federal Reserve's update&nbsp;on monetary policy.</p>\n<p>Futures contracts tied to the Dow Jones Industrial Average were just 46 points lower. S&amp;P 500 futures were largely flat, while Nasdaq 100 futures traded up by 0.1%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/33b560b1ab96b7a340369b24c17d6aa2\" tg-width=\"664\" tg-height=\"233\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:10</span></p>\n<p>The Fed has previously tried to assuage concerns that rising inflation would prompt it to tighten its ultra loose monetary policy, but data on Tuesday showing a jump in producer prices has again raised expectations the central bank could begin debating closing the taps at its meeting this week.</p>\n<p>The central bank's latest policy statement is expected to be released with fresh economic projections at 2 p.m. ET (1800 GMT).</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Oracle(ORCL) </b>– Oracleearned $1.54 per sharefor its latest quarter, beating the consensus estimate of $1.31 a share. The business software company's revenue topped estimates as well. The company forecast current-quarter profit below consensus, however, as it increases investment in its cloud computing operations. Its shares fell 4.7% in premarket trading.</p>\n<p><b>Roblox(RBLX) </b>– Roblox tumbled 7.7% in the premarket after it reported 43 million daily active users for May, up 28% compared to a year earlier but down from 43.3 million in April. Spending by users of the videogame platform was down slightly from a year earlier.</p>\n<p><b>Kindred Biosciences(KIN)</b> – The pet therapeutics company agreed to be acquired byElanco Animal Health(ELAN) for $9.25 per share, or $440 million. Kindred had closed at $6.34 Tuesday, and its stock surged 44.6% in the premarket.</p>\n<p><b>La-Z-Boy(LZB) </b>– La-Z-Boy reported quarterly earnings of 87 cents per share, compared to a consensus estimate of 74 cents a share. The company best known for its reclining chairs also reported better-than-expected revenue. La-Z-Boy said it was being impacted by supply chain issues and significant increases in raw materials prices. Its shares lost 2.3% in the premarket.</p>\n<p><b>H&amp;R Block(HRB)</b> – H&amp;R Block beat Street forecasts for both profit and revenue in its latest quarter, and the tax preparation firm also raised its quarterly dividend by 4% to 27 cents per share. Additionally, H&amp;R Block is shifting the end of its fiscal year to June 30 from April 30, to better capture tax filing activity. H&amp;R Block shares slid 1.1% in premarket action.</p>\n<p><b>EBay(EBAY)</b> – The online marketplace operator will sell its South Korean unit to retailer Shinsegae's E-Mart unit and website operator Naver for about $3.6 billion, according to local media reports. E-Mart acknowledged the talks but said that no deal had been finalized.</p>\n<p><b>General Motors(GM) </b>– GM reportedly plans to boost global spending on electric and autonomous vehicles by 30% from its most recent forecast to a total of $35 billion through 2025. People briefed on the plans told Reuters that the spending will include two additional U.S. battery plants.</p>\n<p><b>Johnson &amp; Johnson(JNJ)</b> – The Food and Drug Administration cleared 15 million more doses of J&amp;J's Covid-19 vaccine that had been produced at a Baltimore plant run byEmergent Biosolutions(EBS). That brings the total of cleared doses to 25 million. Earlier, the FDA had rejected 60 million doses produced at that plant, saying Emergent hadn't taken proper precautions to prevent cross-contamination with another production line that was producingAstraZeneca's(AZN) Covid vaccine.</p>\n<p><b>Southwest Airlines(LUV) </b>– Southwest&nbsp;suffered its second computer glitch in 24 hoursTuesday, with a system outage leading to the cancellation of about 500 flights and delaying many others.</p>\n<p><b>Dish Network(DISH) </b>– The satellite TV company was upgraded to \"buy\" from \"hold\" at Pivotal Research, which cited the potential for Dish's 5G wireless network. Dish rose 1.7% in the premarket.</p>\n<p><b>Apollo Global(APO) </b>– Apollo sold textbook and educational technology company McGraw Hill to private-equity firm Platinum Equity for $4.5 billion.</p>\n<p><b>Regeneron(REGN) </b>– The drugmaker'sCovid-19 antibody cocktailreduced deaths in patients who could not mount their own antibody response, according to a newly published British study.</p>\n<p><b>SoFi Technologies(SOFI) </b>– The financial services platform was rated \"buy\" in new coverage at Rosenblatt Securities, noting SoFi's \"powerful\" cost advantage over legacy banks. SoFi shares rose 2.1% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-16 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures were mostly flat on Wednesday ahead of the&nbsp;Federal Reserve's update&nbsp;on monetary policy.</p>\n<p>Futures contracts tied to the Dow Jones Industrial Average were just 46 points lower. S&amp;P 500 futures were largely flat, while Nasdaq 100 futures traded up by 0.1%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/33b560b1ab96b7a340369b24c17d6aa2\" tg-width=\"664\" tg-height=\"233\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:10</span></p>\n<p>The Fed has previously tried to assuage concerns that rising inflation would prompt it to tighten its ultra loose monetary policy, but data on Tuesday showing a jump in producer prices has again raised expectations the central bank could begin debating closing the taps at its meeting this week.</p>\n<p>The central bank's latest policy statement is expected to be released with fresh economic projections at 2 p.m. ET (1800 GMT).</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Oracle(ORCL) </b>– Oracleearned $1.54 per sharefor its latest quarter, beating the consensus estimate of $1.31 a share. The business software company's revenue topped estimates as well. The company forecast current-quarter profit below consensus, however, as it increases investment in its cloud computing operations. Its shares fell 4.7% in premarket trading.</p>\n<p><b>Roblox(RBLX) </b>– Roblox tumbled 7.7% in the premarket after it reported 43 million daily active users for May, up 28% compared to a year earlier but down from 43.3 million in April. Spending by users of the videogame platform was down slightly from a year earlier.</p>\n<p><b>Kindred Biosciences(KIN)</b> – The pet therapeutics company agreed to be acquired byElanco Animal Health(ELAN) for $9.25 per share, or $440 million. Kindred had closed at $6.34 Tuesday, and its stock surged 44.6% in the premarket.</p>\n<p><b>La-Z-Boy(LZB) </b>– La-Z-Boy reported quarterly earnings of 87 cents per share, compared to a consensus estimate of 74 cents a share. The company best known for its reclining chairs also reported better-than-expected revenue. La-Z-Boy said it was being impacted by supply chain issues and significant increases in raw materials prices. Its shares lost 2.3% in the premarket.</p>\n<p><b>H&amp;R Block(HRB)</b> – H&amp;R Block beat Street forecasts for both profit and revenue in its latest quarter, and the tax preparation firm also raised its quarterly dividend by 4% to 27 cents per share. Additionally, H&amp;R Block is shifting the end of its fiscal year to June 30 from April 30, to better capture tax filing activity. H&amp;R Block shares slid 1.1% in premarket action.</p>\n<p><b>EBay(EBAY)</b> – The online marketplace operator will sell its South Korean unit to retailer Shinsegae's E-Mart unit and website operator Naver for about $3.6 billion, according to local media reports. E-Mart acknowledged the talks but said that no deal had been finalized.</p>\n<p><b>General Motors(GM) </b>– GM reportedly plans to boost global spending on electric and autonomous vehicles by 30% from its most recent forecast to a total of $35 billion through 2025. People briefed on the plans told Reuters that the spending will include two additional U.S. battery plants.</p>\n<p><b>Johnson &amp; Johnson(JNJ)</b> – The Food and Drug Administration cleared 15 million more doses of J&amp;J's Covid-19 vaccine that had been produced at a Baltimore plant run byEmergent Biosolutions(EBS). That brings the total of cleared doses to 25 million. Earlier, the FDA had rejected 60 million doses produced at that plant, saying Emergent hadn't taken proper precautions to prevent cross-contamination with another production line that was producingAstraZeneca's(AZN) Covid vaccine.</p>\n<p><b>Southwest Airlines(LUV) </b>– Southwest&nbsp;suffered its second computer glitch in 24 hoursTuesday, with a system outage leading to the cancellation of about 500 flights and delaying many others.</p>\n<p><b>Dish Network(DISH) </b>– The satellite TV company was upgraded to \"buy\" from \"hold\" at Pivotal Research, which cited the potential for Dish's 5G wireless network. Dish rose 1.7% in the premarket.</p>\n<p><b>Apollo Global(APO) </b>– Apollo sold textbook and educational technology company McGraw Hill to private-equity firm Platinum Equity for $4.5 billion.</p>\n<p><b>Regeneron(REGN) </b>– The drugmaker'sCovid-19 antibody cocktailreduced deaths in patients who could not mount their own antibody response, according to a newly published British study.</p>\n<p><b>SoFi Technologies(SOFI) </b>– The financial services platform was rated \"buy\" in new coverage at Rosenblatt Securities, noting SoFi's \"powerful\" cost advantage over legacy banks. SoFi shares rose 2.1% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","KIN":"Kindred Biosciences, Inc.",".SPX":"S&P 500 Index","ORCL":"甲骨文",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185341836","content_text":"U.S. stock index futures were mostly flat on Wednesday ahead of the Federal Reserve's update on monetary policy.\nFutures contracts tied to the Dow Jones Industrial Average were just 46 points lower. S&P 500 futures were largely flat, while Nasdaq 100 futures traded up by 0.1%.\n*Source From Tiger Trade, EST 08:10\nThe Fed has previously tried to assuage concerns that rising inflation would prompt it to tighten its ultra loose monetary policy, but data on Tuesday showing a jump in producer prices has again raised expectations the central bank could begin debating closing the taps at its meeting this week.\nThe central bank's latest policy statement is expected to be released with fresh economic projections at 2 p.m. ET (1800 GMT).\nStocks making the biggest moves in the premarket:\nOracle(ORCL) – Oracleearned $1.54 per sharefor its latest quarter, beating the consensus estimate of $1.31 a share. The business software company's revenue topped estimates as well. The company forecast current-quarter profit below consensus, however, as it increases investment in its cloud computing operations. Its shares fell 4.7% in premarket trading.\nRoblox(RBLX) – Roblox tumbled 7.7% in the premarket after it reported 43 million daily active users for May, up 28% compared to a year earlier but down from 43.3 million in April. Spending by users of the videogame platform was down slightly from a year earlier.\nKindred Biosciences(KIN) – The pet therapeutics company agreed to be acquired byElanco Animal Health(ELAN) for $9.25 per share, or $440 million. Kindred had closed at $6.34 Tuesday, and its stock surged 44.6% in the premarket.\nLa-Z-Boy(LZB) – La-Z-Boy reported quarterly earnings of 87 cents per share, compared to a consensus estimate of 74 cents a share. The company best known for its reclining chairs also reported better-than-expected revenue. La-Z-Boy said it was being impacted by supply chain issues and significant increases in raw materials prices. Its shares lost 2.3% in the premarket.\nH&R Block(HRB) – H&R Block beat Street forecasts for both profit and revenue in its latest quarter, and the tax preparation firm also raised its quarterly dividend by 4% to 27 cents per share. Additionally, H&R Block is shifting the end of its fiscal year to June 30 from April 30, to better capture tax filing activity. H&R Block shares slid 1.1% in premarket action.\nEBay(EBAY) – The online marketplace operator will sell its South Korean unit to retailer Shinsegae's E-Mart unit and website operator Naver for about $3.6 billion, according to local media reports. E-Mart acknowledged the talks but said that no deal had been finalized.\nGeneral Motors(GM) – GM reportedly plans to boost global spending on electric and autonomous vehicles by 30% from its most recent forecast to a total of $35 billion through 2025. People briefed on the plans told Reuters that the spending will include two additional U.S. battery plants.\nJohnson & Johnson(JNJ) – The Food and Drug Administration cleared 15 million more doses of J&J's Covid-19 vaccine that had been produced at a Baltimore plant run byEmergent Biosolutions(EBS). That brings the total of cleared doses to 25 million. Earlier, the FDA had rejected 60 million doses produced at that plant, saying Emergent hadn't taken proper precautions to prevent cross-contamination with another production line that was producingAstraZeneca's(AZN) Covid vaccine.\nSouthwest Airlines(LUV) – Southwest suffered its second computer glitch in 24 hoursTuesday, with a system outage leading to the cancellation of about 500 flights and delaying many others.\nDish Network(DISH) – The satellite TV company was upgraded to \"buy\" from \"hold\" at Pivotal Research, which cited the potential for Dish's 5G wireless network. Dish rose 1.7% in the premarket.\nApollo Global(APO) – Apollo sold textbook and educational technology company McGraw Hill to private-equity firm Platinum Equity for $4.5 billion.\nRegeneron(REGN) – The drugmaker'sCovid-19 antibody cocktailreduced deaths in patients who could not mount their own antibody response, according to a newly published British study.\nSoFi Technologies(SOFI) – The financial services platform was rated \"buy\" in new coverage at Rosenblatt Securities, noting SoFi's \"powerful\" cost advantage over legacy banks. SoFi shares rose 2.1% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182342837,"gmtCreate":1623555576529,"gmtModify":1704206057748,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"But the risk is small and may have other triggering factors&nbsp;","listText":"But the risk is small and may have other triggering factors&nbsp;","text":"But the risk is small and may have other triggering factors","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182342837","repostId":"2142206311","repostType":4,"repost":{"id":"2142206311","pubTimestamp":1623426552,"share":"https://www.laohu8.com/m/news/2142206311?lang=&edition=full","pubTime":"2021-06-11 23:49","market":"us","language":"en","title":"COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart","url":"https://stock-news.laohu8.com/highlight/detail?id=2142206311","media":"Zacks","summary":"The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention  stated that it has observed increased cases of heart inflammation in adolescents and younger adults, especially aged 12 to 24, following inoculation with authorized mRNA-based COVID-19 vaccines from Moderna MRNA, and Pfizer PFE/BioNTech BNTX.Several hundreds of cases of myocarditis and pericarditis, both conditions of heart inflammation, were reported to the U.S. government’s VAERS  following dose 1 of any mR","content":"<p>The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention (CDC) stated that it has observed increased cases of heart inflammation in adolescents and younger adults, especially aged 12 to 24, following inoculation with authorized mRNA-based COVID-19 vaccines from <b>Moderna</b> MRNA, and <b>Pfizer</b> PFE/<b>BioNTech</b> BNTX.</p><p>Several hundreds of cases of myocarditis and pericarditis, both conditions of heart inflammation, were reported to the U.S. government’s VAERS (Vaccine Adverse Event Reporting System) following dose 1 of any mRNA-based vaccine in the last two months. Please note that VAERS is a national early warning system to detect possible safety problems in U.S. licensed vaccines. The number of cases increased further after the second dose of these vaccines. Moreover, the cases occurred in higher number of younger patients following dose 2 compared to dose 1. The CDC stated that similar inflammation cases were not reported following vaccination with <b>J&amp;J</b>’s JNJ adenovirus-based COVID-19 vaccine.</p><h3>Israeli Alarm</h3><p>Per a Reuters report, the Israel’s Health Ministry raised the alarm when it reported a likely link of heart inflammation in young men vaccinated with Pfizer’s BNT162b earlier this month. Following this report, the CDC and health regulators in other countries started investigating such cases.</p><p>Although the number of reported cases is small compared to total inoculations with mRNA vaccines, they were higher than expected in the younger age groups.</p><h3>CDC Meeting</h3><p>We note that the CDC is yet to link these adverse events to mRNA vaccines and has scheduled a meeting of the Advisory Committee on Immunization Practices (ACIP) on Jun 18 to discuss and assess the heart inflammation reports. Moreover, the government authority has recommended continuation of vaccination for everyone of age 12 or older given the risk of COVID-19 illness and related complications.</p><p>However, we note that the CDC report also stated that more than 50% of heart inflammation cases were reported in the age group of 12-24 that has received only 8.8% of vaccine doses. This suggests that any adverse outcome from the ACIP meeting scheduled next week can hamper vaccination with mRNA vaccines in the adolescent patient group, and hurt prospects of these vaccine developers. However, the percentage of inflammation cases suggests that the risk from these vaccines is significantly lower than their benefits. A CDC study claims that these vaccines are 91% effective. Moreover, most patients facing inflammation issues quickly felt better following medication and rest.</p><h3>mRNA Vaccine Updates</h3><p>We remind investors that Pfizer/BioNTech’s COVID-19 vaccine received authorization for emergency use in adolescents last month from the FDA. Moderna filed for a similar authorization in the United States, Europe and Canada earlier this month.</p><p>Meanwhile, Pfizer and BioNTech have pledged two billion doses of their COVID-19 vaccines to ensure equitable access to their vaccines globally. As part of the pledge, the company plans to supply 200 million doses in 2021 and 300 million doses in the first half of 2022 to the U.S. government at not-for-profit price. The government will donate these doses to low- and lower middle-income countries and organizations that support them.</p><p>While Moderna and Pfizer carry a Zacks Rank #3 (Hold), BioNTech sports a Zacks Rank of 1 (Strong Buy). </p><p>Pfizer,&nbsp;Moderna&nbsp;fell&nbsp;over&nbsp;1%&nbsp;in&nbsp;morning&nbsp;trading.</p><p><img src=\"https://static.tigerbbs.com/4abafe1ebf6b0259e6f305a5483d4a2a\" tg-width=\"700\" tg-height=\"584\"><img src=\"https://static.tigerbbs.com/16bd6a310a9f80f7ecaf40c96b582198\" tg-width=\"700\" tg-height=\"584\"></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCOVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 23:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/covid-19-jabs-pfizer-moderna-124412703.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention (CDC) stated that it has observed increased cases of heart inflammation in adolescents and younger adults, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/covid-19-jabs-pfizer-moderna-124412703.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/i.kaShYr9WLQwJ3VXlE4CA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/aNEP4MqN0KfFI8mDHT.6JQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0bba00e006cf8b1987f4ca39d28c5938","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/covid-19-jabs-pfizer-moderna-124412703.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142206311","content_text":"The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention (CDC) stated that it has observed increased cases of heart inflammation in adolescents and younger adults, especially aged 12 to 24, following inoculation with authorized mRNA-based COVID-19 vaccines from Moderna MRNA, and Pfizer PFE/BioNTech BNTX.Several hundreds of cases of myocarditis and pericarditis, both conditions of heart inflammation, were reported to the U.S. government’s VAERS (Vaccine Adverse Event Reporting System) following dose 1 of any mRNA-based vaccine in the last two months. Please note that VAERS is a national early warning system to detect possible safety problems in U.S. licensed vaccines. The number of cases increased further after the second dose of these vaccines. Moreover, the cases occurred in higher number of younger patients following dose 2 compared to dose 1. The CDC stated that similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine.Israeli AlarmPer a Reuters report, the Israel’s Health Ministry raised the alarm when it reported a likely link of heart inflammation in young men vaccinated with Pfizer’s BNT162b earlier this month. Following this report, the CDC and health regulators in other countries started investigating such cases.Although the number of reported cases is small compared to total inoculations with mRNA vaccines, they were higher than expected in the younger age groups.CDC MeetingWe note that the CDC is yet to link these adverse events to mRNA vaccines and has scheduled a meeting of the Advisory Committee on Immunization Practices (ACIP) on Jun 18 to discuss and assess the heart inflammation reports. Moreover, the government authority has recommended continuation of vaccination for everyone of age 12 or older given the risk of COVID-19 illness and related complications.However, we note that the CDC report also stated that more than 50% of heart inflammation cases were reported in the age group of 12-24 that has received only 8.8% of vaccine doses. This suggests that any adverse outcome from the ACIP meeting scheduled next week can hamper vaccination with mRNA vaccines in the adolescent patient group, and hurt prospects of these vaccine developers. However, the percentage of inflammation cases suggests that the risk from these vaccines is significantly lower than their benefits. A CDC study claims that these vaccines are 91% effective. Moreover, most patients facing inflammation issues quickly felt better following medication and rest.mRNA Vaccine UpdatesWe remind investors that Pfizer/BioNTech’s COVID-19 vaccine received authorization for emergency use in adolescents last month from the FDA. Moderna filed for a similar authorization in the United States, Europe and Canada earlier this month.Meanwhile, Pfizer and BioNTech have pledged two billion doses of their COVID-19 vaccines to ensure equitable access to their vaccines globally. As part of the pledge, the company plans to supply 200 million doses in 2021 and 300 million doses in the first half of 2022 to the U.S. government at not-for-profit price. The government will donate these doses to low- and lower middle-income countries and organizations that support them.While Moderna and Pfizer carry a Zacks Rank #3 (Hold), BioNTech sports a Zacks Rank of 1 (Strong Buy). Pfizer, Moderna fell over 1% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":193090203,"gmtCreate":1620738590202,"gmtModify":1704347610931,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"All crashing&nbsp;","listText":"All crashing&nbsp;","text":"All crashing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/193090203","repostId":"1171636052","repostType":4,"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":193007811,"gmtCreate":1620738532633,"gmtModify":1704347610606,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"To sell or to keep?&nbsp;","listText":"To sell or to keep?&nbsp;","text":"To sell or to keep?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/193007811","repostId":"1101624279","repostType":4,"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371649536,"gmtCreate":1618933484625,"gmtModify":1704717194113,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371649536","repostId":"2128841791","repostType":4,"repost":{"id":"2128841791","pubTimestamp":1618932901,"share":"https://www.laohu8.com/m/news/2128841791?lang=&edition=full","pubTime":"2021-04-20 23:35","market":"us","language":"en","title":"Snap Earnings: Here's What to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2128841791","media":"Motley Fool","summary":"Expectations are high. Can the social media company deliver?","content":"<p>One of the most interesting earnings reports this week may be <b>Snap</b>'s (NYSE:SNAP). The parent company of social media platform Snapchat will give investors <a href=\"https://laohu8.com/S/AONE\">one</a> of the first glimpses into how digital advertising is faring in 2021.</p>\n<p>Snapchat is a fast-growing platform with soaring digital advertising revenue. Expectations, therefore, are unsurprisingly high. Can the tech company deliver when it reports its first-quarter results on Thursday?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/067b87a19abf33877fb63d4d59383146\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>Impressive momentum</h2>\n<p>Snapchat wrapped up 2020 with staggering momentum. Total fourth-quarter revenue rose 62% year over year to $911 million. This put total 2020 revenue at $2.5 billion, up 46% year over year.</p>\n<p>This top-line strength was fueled by a 22% year-over-year increase in daily active users and strength in average revenue per user (ARPU). ARPU increased 33% in the fourth quarter of 2020 versus the year-ago quarter.</p>\n<p>\"We continued to see strong adoption of our advertising products in Q4,\" explained Snap CFO Derek Andersen said about the company's growth drivers in Snap's fourth-quarter earnings call. Andersen continued:</p>\n<blockquote>\n Revenue from our commercials ad product more than doubled year-over-year in Q4 as we continue to see building demand from advertisers seeking to reach Gen Z and Millennial audiences at scale, and with a full screen video advertising product that is delivered adjacent to brand safe content.\n</blockquote>\n<h2>Why growth could accelerate</h2>\n<p>For Snapchat's first quarter of 2021, analysts are modeling for a slight deceleration in the social network company's revenue growth. On average, analysts are expecting Snapchat's revenue to increase 61% year over year. This is above management's guidance range for first-quarter revenue to increase 56% to 60% year over year.</p>\n<p>But it's possible that analysts are undershooting, even though the company's guidance range is lower than the consensus forecast. Management guidance typically proves to be quite conservative, barring the fourth quarter of 2019 when the company didn't anticipate lockdowns resulting from COVID-19 in late Q1 2020. If you rewind back to more normalized quarters pre-COVID, consider that Snapchat's revenue came in ahead of its guidance range in every quarter in 2019.</p>\n<p>If the company's track record of approaching its revenue guidance with conservatism is any indication of how Snap's first-quarter top line may trend, the company may not only beat analysts' forecasts but even post a higher growth rate than it did in Q4.</p>\n<p>Of course, there's no guarantee this happens. These are unprecedented times for both ad buyers and digital advertising platforms. In addition, there's elevated uncertainty for many companies. This makes forecasting for both management and analysts particularly tricky.</p>\n<p>Whatever happens, Snap's first-quarter revenue growth may shed light on how the overall digital advertising industry is doing in Q1. A stronger-than-expected quarter from the company could suggest many digital advertising companies are doing well. A weaker-than-expected quarter, on the other hand, could mean that advertisers are holding back. For Snap specifically, a strong quarter could highlight strength in the company's ad products and Snap's ability to capture wallet share from advertisers as the economy reopens.</p>\n<p>Snap reports its first-quarter results after market close on Thursday, Apr. 22.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snap Earnings: Here's What to Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnap Earnings: Here's What to Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 23:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/snap-earnings-heres-what-to-watch/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the most interesting earnings reports this week may be Snap's (NYSE:SNAP). The parent company of social media platform Snapchat will give investors one of the first glimpses into how digital ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/snap-earnings-heres-what-to-watch/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNAP":"Snap Inc"},"source_url":"https://www.fool.com/investing/2021/04/20/snap-earnings-heres-what-to-watch/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128841791","content_text":"One of the most interesting earnings reports this week may be Snap's (NYSE:SNAP). The parent company of social media platform Snapchat will give investors one of the first glimpses into how digital advertising is faring in 2021.\nSnapchat is a fast-growing platform with soaring digital advertising revenue. Expectations, therefore, are unsurprisingly high. Can the tech company deliver when it reports its first-quarter results on Thursday?\nImage source: Getty Images.\nImpressive momentum\nSnapchat wrapped up 2020 with staggering momentum. Total fourth-quarter revenue rose 62% year over year to $911 million. This put total 2020 revenue at $2.5 billion, up 46% year over year.\nThis top-line strength was fueled by a 22% year-over-year increase in daily active users and strength in average revenue per user (ARPU). ARPU increased 33% in the fourth quarter of 2020 versus the year-ago quarter.\n\"We continued to see strong adoption of our advertising products in Q4,\" explained Snap CFO Derek Andersen said about the company's growth drivers in Snap's fourth-quarter earnings call. Andersen continued:\n\n Revenue from our commercials ad product more than doubled year-over-year in Q4 as we continue to see building demand from advertisers seeking to reach Gen Z and Millennial audiences at scale, and with a full screen video advertising product that is delivered adjacent to brand safe content.\n\nWhy growth could accelerate\nFor Snapchat's first quarter of 2021, analysts are modeling for a slight deceleration in the social network company's revenue growth. On average, analysts are expecting Snapchat's revenue to increase 61% year over year. This is above management's guidance range for first-quarter revenue to increase 56% to 60% year over year.\nBut it's possible that analysts are undershooting, even though the company's guidance range is lower than the consensus forecast. Management guidance typically proves to be quite conservative, barring the fourth quarter of 2019 when the company didn't anticipate lockdowns resulting from COVID-19 in late Q1 2020. If you rewind back to more normalized quarters pre-COVID, consider that Snapchat's revenue came in ahead of its guidance range in every quarter in 2019.\nIf the company's track record of approaching its revenue guidance with conservatism is any indication of how Snap's first-quarter top line may trend, the company may not only beat analysts' forecasts but even post a higher growth rate than it did in Q4.\nOf course, there's no guarantee this happens. These are unprecedented times for both ad buyers and digital advertising platforms. In addition, there's elevated uncertainty for many companies. This makes forecasting for both management and analysts particularly tricky.\nWhatever happens, Snap's first-quarter revenue growth may shed light on how the overall digital advertising industry is doing in Q1. A stronger-than-expected quarter from the company could suggest many digital advertising companies are doing well. A weaker-than-expected quarter, on the other hand, could mean that advertisers are holding back. For Snap specifically, a strong quarter could highlight strength in the company's ad products and Snap's ability to capture wallet share from advertisers as the economy reopens.\nSnap reports its first-quarter results after market close on Thursday, Apr. 22.","news_type":1},"isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371640091,"gmtCreate":1618933390613,"gmtModify":1704717192491,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371640091","repostId":"1164936386","repostType":4,"repost":{"id":"1164936386","pubTimestamp":1618841871,"share":"https://www.laohu8.com/m/news/1164936386?lang=&edition=full","pubTime":"2021-04-19 22:17","market":"us","language":"en","title":"Should You Buy Apple Stock Before Next Apple Event?","url":"https://stock-news.laohu8.com/highlight/detail?id=1164936386","media":"TheStreet","summary":"On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Ap","content":"<p>On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.</p>\n<p>A&nbsp;new Apple Event lurks around the corner. Beyond the curiosity for what new products will be unveiled, investors will also pay attention to how Apple stock will behave. Below, the Apple Maven reviews how the previous events aﬀected share price behavior in 2020.</p>\n<p><b>The effect of Apple events on the stock</b></p>\n<ul>\n <li><b>Apple’s “One More Thing” – November 30, 2020</b>:The highlight of the event&nbsp;was Apple’s introduction of the M1-equipped MacBook Air, 13‑inch MacBook Pro and Mac mini. In the following three months, the stock climbed 23%, reaching all-time highs by January 2021.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ef348206ee5454f0af9c8828e7906b91\" tg-width=\"1240\" tg-height=\"361\"><span>Figure 1: Apple stock performance after \"One More Thing\" event.</span></p>\n<ul>\n <li><b>Apple’s “Hi, Speed” – October 13, 2020</b>:The Cupertino company introduced&nbsp;the highly anticipated iPhone 12 and iPhone 12 Pro with 5G connectivity, MagSafe accessories, and the HomePod mini. This could be considered the main event of the year, since the iPhone is Apple’s key revenue driver. However, the stock dropped 4% between the iPhone launch and the “One More Thing” event.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9c24a3a51e2e31f611a844d66b0a0255\" tg-width=\"1240\" tg-height=\"367\"><span>Figure 2: Apple stock performance after \"Hi, Speed\" event.</span></p>\n<ul>\n <li><b>Apple’s “Time Flies” – September 15, 2020</b>:In this action-packed event, the Apple Watch Series 6, Apple Watch SE, the new iPad Air and iPad, Apple Fitness+ and Apple One were introduced. Apple stock climbed 4% in the six weeks between “Time Flies” and “Hi, Speed”.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a232bac33db421d697d4ebb8cabccd96\" tg-width=\"1240\" tg-height=\"368\"><span>Figure 3: Apple stock performance after \"Time Flies\" event.</span></p>\n<ul>\n <li><b>Apple’s WWDC – June 22, 2020</b>: In the2020 version of the Worldwide Developers Conference, updates to iOS, iPadOS, watchOS and macOS Big Sur were announced. Very importantly, Apple’s introduction of the M1 chip also took center stage. The conference was hosted online for the first time, due to the COVID-19 pandemic. In the following 3 months, Apple shares climbed an impressive 50% to its early September peak.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/adfa652d946092e94e4a8ba657e950a0\" tg-width=\"1240\" tg-height=\"370\"><span>Figure 4: Apple stock performance after \"WWDC\" event.</span></p>\n<p><b>What about the next Apple Event?</b></p>\n<p>At least in 2020, Apple stock performed generally well in the days following the company’s events – although it is hard to establish causation with much certainty. Investors who bought shares ahead of the key dates, except for “Hi, Speed”, saw decent gains in a short period.</p>\n<p>But will the upcoming event guide the stock higher this time?</p>\n<p>The Apple Maven doubts&nbsp;that the iPad, the likely star of Tuesday’s announcements, will be a game changer for Apple stock the same way that the iPhone or new products in mixed reality and autonomous vehicles could be. But it is important for Apple to keep the momentum going in the tablet business, taking advantage of trends in work-from-home and tablet-as-a-PC.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should You Buy Apple Stock Before Next Apple Event?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould You Buy Apple Stock Before Next Apple Event?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-19 22:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.\nA new...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164936386","content_text":"On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.\nA new Apple Event lurks around the corner. Beyond the curiosity for what new products will be unveiled, investors will also pay attention to how Apple stock will behave. Below, the Apple Maven reviews how the previous events aﬀected share price behavior in 2020.\nThe effect of Apple events on the stock\n\nApple’s “One More Thing” – November 30, 2020:The highlight of the event was Apple’s introduction of the M1-equipped MacBook Air, 13‑inch MacBook Pro and Mac mini. In the following three months, the stock climbed 23%, reaching all-time highs by January 2021.\n\nFigure 1: Apple stock performance after \"One More Thing\" event.\n\nApple’s “Hi, Speed” – October 13, 2020:The Cupertino company introduced the highly anticipated iPhone 12 and iPhone 12 Pro with 5G connectivity, MagSafe accessories, and the HomePod mini. This could be considered the main event of the year, since the iPhone is Apple’s key revenue driver. However, the stock dropped 4% between the iPhone launch and the “One More Thing” event.\n\nFigure 2: Apple stock performance after \"Hi, Speed\" event.\n\nApple’s “Time Flies” – September 15, 2020:In this action-packed event, the Apple Watch Series 6, Apple Watch SE, the new iPad Air and iPad, Apple Fitness+ and Apple One were introduced. Apple stock climbed 4% in the six weeks between “Time Flies” and “Hi, Speed”.\n\nFigure 3: Apple stock performance after \"Time Flies\" event.\n\nApple’s WWDC – June 22, 2020: In the2020 version of the Worldwide Developers Conference, updates to iOS, iPadOS, watchOS and macOS Big Sur were announced. Very importantly, Apple’s introduction of the M1 chip also took center stage. The conference was hosted online for the first time, due to the COVID-19 pandemic. In the following 3 months, Apple shares climbed an impressive 50% to its early September peak.\n\nFigure 4: Apple stock performance after \"WWDC\" event.\nWhat about the next Apple Event?\nAt least in 2020, Apple stock performed generally well in the days following the company’s events – although it is hard to establish causation with much certainty. Investors who bought shares ahead of the key dates, except for “Hi, Speed”, saw decent gains in a short period.\nBut will the upcoming event guide the stock higher this time?\nThe Apple Maven doubts that the iPad, the likely star of Tuesday’s announcements, will be a game changer for Apple stock the same way that the iPhone or new products in mixed reality and autonomous vehicles could be. But it is important for Apple to keep the momentum going in the tablet business, taking advantage of trends in work-from-home and tablet-as-a-PC.","news_type":1},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":193090203,"gmtCreate":1620738590202,"gmtModify":1704347610931,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"All crashing&nbsp;","listText":"All crashing&nbsp;","text":"All crashing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/193090203","repostId":"1171636052","repostType":4,"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120477113,"gmtCreate":1624335432832,"gmtModify":1703833814833,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/120477113","repostId":"1134679198","repostType":4,"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3579764463709225","authorId":"3579764463709225","name":"AhKeong","avatar":"https://community-static.tradeup.com/news/b20c0291da6c54ef8f3c421a4ed45c27","crmLevel":2,"crmLevelSwitch":1},"content":"that's Cool. comment n like","text":"that's Cool. comment n like","html":"that's Cool. comment n like"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163343016,"gmtCreate":1623860473335,"gmtModify":1703821842138,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/163343016","repostId":"1185341836","repostType":4,"isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182342837,"gmtCreate":1623555576529,"gmtModify":1704206057748,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"But the risk is small and may have other triggering factors&nbsp;","listText":"But the risk is small and may have other triggering factors&nbsp;","text":"But the risk is small and may have other triggering factors","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182342837","repostId":"2142206311","repostType":4,"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121778542,"gmtCreate":1624494131986,"gmtModify":1703838188780,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yay finally got a T!&nbsp;","listText":"Yay finally got a T!&nbsp;","text":"Yay finally got a T!","images":[{"img":"https://static.tigerbbs.com/41e1cda6782c1b9e8393b0621a66683c","width":"1080","height":"2685"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121778542","isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121638689,"gmtCreate":1624461089041,"gmtModify":1703837534144,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SQ\">$Square(SQ)$</a>?","listText":"<a href=\"https://laohu8.com/S/SQ\">$Square(SQ)$</a>?","text":"$Square(SQ)$?","images":[{"img":"https://static.tigerbbs.com/ce7e770b0eca75081665081998ce062d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121638689","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121108782,"gmtCreate":1624455857946,"gmtModify":1703837223403,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121108782","repostId":"2145283099","repostType":4,"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167466964,"gmtCreate":1624282663258,"gmtModify":1703832357074,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167466964","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading ","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1},"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371649536,"gmtCreate":1618933484625,"gmtModify":1704717194113,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371649536","repostId":"2128841791","repostType":4,"isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":371640091,"gmtCreate":1618933390613,"gmtModify":1704717192491,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371640091","repostId":"1164936386","repostType":4,"repost":{"id":"1164936386","pubTimestamp":1618841871,"share":"https://www.laohu8.com/m/news/1164936386?lang=&edition=full","pubTime":"2021-04-19 22:17","market":"us","language":"en","title":"Should You Buy Apple Stock Before Next Apple Event?","url":"https://stock-news.laohu8.com/highlight/detail?id=1164936386","media":"TheStreet","summary":"On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Ap","content":"<p>On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.</p>\n<p>A&nbsp;new Apple Event lurks around the corner. Beyond the curiosity for what new products will be unveiled, investors will also pay attention to how Apple stock will behave. Below, the Apple Maven reviews how the previous events aﬀected share price behavior in 2020.</p>\n<p><b>The effect of Apple events on the stock</b></p>\n<ul>\n <li><b>Apple’s “One More Thing” – November 30, 2020</b>:The highlight of the event&nbsp;was Apple’s introduction of the M1-equipped MacBook Air, 13‑inch MacBook Pro and Mac mini. In the following three months, the stock climbed 23%, reaching all-time highs by January 2021.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ef348206ee5454f0af9c8828e7906b91\" tg-width=\"1240\" tg-height=\"361\"><span>Figure 1: Apple stock performance after \"One More Thing\" event.</span></p>\n<ul>\n <li><b>Apple’s “Hi, Speed” – October 13, 2020</b>:The Cupertino company introduced&nbsp;the highly anticipated iPhone 12 and iPhone 12 Pro with 5G connectivity, MagSafe accessories, and the HomePod mini. This could be considered the main event of the year, since the iPhone is Apple’s key revenue driver. However, the stock dropped 4% between the iPhone launch and the “One More Thing” event.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9c24a3a51e2e31f611a844d66b0a0255\" tg-width=\"1240\" tg-height=\"367\"><span>Figure 2: Apple stock performance after \"Hi, Speed\" event.</span></p>\n<ul>\n <li><b>Apple’s “Time Flies” – September 15, 2020</b>:In this action-packed event, the Apple Watch Series 6, Apple Watch SE, the new iPad Air and iPad, Apple Fitness+ and Apple One were introduced. Apple stock climbed 4% in the six weeks between “Time Flies” and “Hi, Speed”.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a232bac33db421d697d4ebb8cabccd96\" tg-width=\"1240\" tg-height=\"368\"><span>Figure 3: Apple stock performance after \"Time Flies\" event.</span></p>\n<ul>\n <li><b>Apple’s WWDC – June 22, 2020</b>: In the2020 version of the Worldwide Developers Conference, updates to iOS, iPadOS, watchOS and macOS Big Sur were announced. Very importantly, Apple’s introduction of the M1 chip also took center stage. The conference was hosted online for the first time, due to the COVID-19 pandemic. In the following 3 months, Apple shares climbed an impressive 50% to its early September peak.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/adfa652d946092e94e4a8ba657e950a0\" tg-width=\"1240\" tg-height=\"370\"><span>Figure 4: Apple stock performance after \"WWDC\" event.</span></p>\n<p><b>What about the next Apple Event?</b></p>\n<p>At least in 2020, Apple stock performed generally well in the days following the company’s events – although it is hard to establish causation with much certainty. Investors who bought shares ahead of the key dates, except for “Hi, Speed”, saw decent gains in a short period.</p>\n<p>But will the upcoming event guide the stock higher this time?</p>\n<p>The Apple Maven doubts&nbsp;that the iPad, the likely star of Tuesday’s announcements, will be a game changer for Apple stock the same way that the iPhone or new products in mixed reality and autonomous vehicles could be. But it is important for Apple to keep the momentum going in the tablet business, taking advantage of trends in work-from-home and tablet-as-a-PC.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should You Buy Apple Stock Before Next Apple Event?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould You Buy Apple Stock Before Next Apple Event?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-19 22:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.\nA new...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164936386","content_text":"On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.\nA new Apple Event lurks around the corner. Beyond the curiosity for what new products will be unveiled, investors will also pay attention to how Apple stock will behave. Below, the Apple Maven reviews how the previous events aﬀected share price behavior in 2020.\nThe effect of Apple events on the stock\n\nApple’s “One More Thing” – November 30, 2020:The highlight of the event was Apple’s introduction of the M1-equipped MacBook Air, 13‑inch MacBook Pro and Mac mini. In the following three months, the stock climbed 23%, reaching all-time highs by January 2021.\n\nFigure 1: Apple stock performance after \"One More Thing\" event.\n\nApple’s “Hi, Speed” – October 13, 2020:The Cupertino company introduced the highly anticipated iPhone 12 and iPhone 12 Pro with 5G connectivity, MagSafe accessories, and the HomePod mini. This could be considered the main event of the year, since the iPhone is Apple’s key revenue driver. However, the stock dropped 4% between the iPhone launch and the “One More Thing” event.\n\nFigure 2: Apple stock performance after \"Hi, Speed\" event.\n\nApple’s “Time Flies” – September 15, 2020:In this action-packed event, the Apple Watch Series 6, Apple Watch SE, the new iPad Air and iPad, Apple Fitness+ and Apple One were introduced. Apple stock climbed 4% in the six weeks between “Time Flies” and “Hi, Speed”.\n\nFigure 3: Apple stock performance after \"Time Flies\" event.\n\nApple’s WWDC – June 22, 2020: In the2020 version of the Worldwide Developers Conference, updates to iOS, iPadOS, watchOS and macOS Big Sur were announced. Very importantly, Apple’s introduction of the M1 chip also took center stage. The conference was hosted online for the first time, due to the COVID-19 pandemic. In the following 3 months, Apple shares climbed an impressive 50% to its early September peak.\n\nFigure 4: Apple stock performance after \"WWDC\" event.\nWhat about the next Apple Event?\nAt least in 2020, Apple stock performed generally well in the days following the company’s events – although it is hard to establish causation with much certainty. Investors who bought shares ahead of the key dates, except for “Hi, Speed”, saw decent gains in a short period.\nBut will the upcoming event guide the stock higher this time?\nThe Apple Maven doubts that the iPad, the likely star of Tuesday’s announcements, will be a game changer for Apple stock the same way that the iPhone or new products in mixed reality and autonomous vehicles could be. But it is important for Apple to keep the momentum going in the tablet business, taking advantage of trends in work-from-home and tablet-as-a-PC.","news_type":1},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120916632,"gmtCreate":1624291687426,"gmtModify":1703832754617,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120916632","repostId":"1127414335","repostType":4,"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":193007811,"gmtCreate":1620738532633,"gmtModify":1704347610606,"author":{"id":"3582025009793897","authorId":"3582025009793897","name":"funkykoh","avatar":"https://static.tigerbbs.com/4d8ac2b302d0f306dda0b8972a050851","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"To sell or to keep?&nbsp;","listText":"To sell or to keep?&nbsp;","text":"To sell or to keep?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/193007811","repostId":"1101624279","repostType":4,"repost":{"id":"1101624279","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620734279,"share":"https://www.laohu8.com/m/news/1101624279?lang=&edition=full","pubTime":"2021-05-11 19:57","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1101624279","media":"Tiger Newspress","summary":"Reflation panic sparks global stock rout.Tech rout is set to continue with Nasdaq 100 futures falling more than 1%.Most of Blockchain stocks fell over 10%.Tesla plunge over 6%.FAAMG dipped, Apple fell about 3%.Pipeline shuttered by cyberattack to restore service by end of the week. Stock-index futures pointed to further losses for equities on Tuesday, with inflation worries seen keeping pressure on previously highflying tech stocks.At 7:52 a.m. ET, Dow E-minis were fell 185 points, or 0.53%, S&P","content":"<ul><li>Reflation panic sparks global stock rout.</li><li>Tech rout is set to continue with Nasdaq 100 futures falling more than 1%.</li><li>Most of&nbsp;Blockchain stocks fell over 10%.</li><li>Tesla plunge over 6%.</li><li>FAAMG&nbsp;dipped,&nbsp;Apple fell about 3%.</li><li>Pipeline shuttered by cyberattack to restore service by end of the week.</li></ul><p>(May 11)&nbsp;Stock-index futures pointed to further losses for equities on Tuesday, with inflation worries seen keeping pressure on previously highflying tech stocks.</p><p>At 7:52 a.m. ET, Dow E-minis were fell 185 points, or 0.53%, S&amp;P 500 E-minis were down 37 points, or 0.88% and Nasdaq 100 E-minis were down 199.75 points, or 1.50%.</p><p><img src=\"https://static.tigerbbs.com/1a570ec329301f9a7665cab3c468d0b9\" tg-width=\"1242\" tg-height=\"488\" referrerpolicy=\"no-referrer\"></p><p>On Monday, a tech-led selloff sent the Nasdaq Composite&nbsp;down 2.6% to its lowest close since March 31, while the S&amp;P 500&nbsp;slumped 1%. The Dow&nbsp;gave up a gain of more than 300 points that had taken it to an all-time high above 35,000 to end the day down 34.94 points, or 0.1%.</p><p><b>What’s driving the market?</b></p><p>Further pressure on Big Tech shares appeared in store, with shares of Facebook Inc.&nbsp;Apple Inc.&nbsp;,Amazon.com Inc.&nbsp;,Netflix Inc.&nbsp;,Microsoft Corp.&nbsp;and Google parent Alphabet Inc.&nbsp;down more than 1% in premarket activity.</p><p>Apple fell about 3%,&nbsp;iPhone 12 Production Sees Over 50% Slump At Apple Supplier Foxconn's Factory In India With COVID-19.</p><p>Tesla&nbsp;shares fell nearly 4% in premarket trading as Reuters reported the electric car maker and bellwether growth play halted plans to expand its Shanghai plant into an export hub.</p><p>Most of&nbsp;Blockchain stocks fell over 10%.</p><p><img src=\"https://static.tigerbbs.com/a9ae979de807b94981438e195f617d2f\" tg-width=\"308\" tg-height=\"282\" referrerpolicy=\"no-referrer\"></p><p>“There isn’t a clear catalyst behind this purge,” said Marios Hadjikyriacos, investment analyst at XM, in a note. “It seems to be a combination of inflation fears making a comeback and some market participants moving higher along the value spectrum, cutting their exposure to anything with a stretched valuation.”</p><p>The fact that the selloff has been mostly concentrated in tech and growth stocks, however, is encouraging in terms of the overall market outlook, Hadjikyriacos said, because it indicates investors haven’t lost faith in the economic outlook but are moving away from “more speculative” positions, which could even calm some “bubble concerns, considering what is being sold.”</p><p>Investors continue to focus on the labor market after a much smaller-than-expected rise in nonfarm payrolls in March was reported on Friday.</p><p>The National Federation of Independent Business said Tuesday its monthly survey founda record 44%of small businesses said job openings went unfilled in April.</p><p>Data on U.S. March job openings is due at 10 a.m. Eastern.</p><p>Investors will also hear from several Federal Reserve officials on Tuesday, including New York Fed President John Williams, Fed Gov. Lael Brainard, San Francisco President Mary Daly, Atlanta Fed Raphael Bostic, Philadelphia Fed President Patrick Harker, and Minneapolis Fed President Neel Kashkari.</p><p><b>Stocks making the biggest moves in the premarket: Virgin Galactic, Callaway Golf, Palantir &amp; more</b></p><p>1)&nbsp;Virgin Galactic(SPCE) – Virgin Galactic shares tanked 19.9% in premarket action. The companylost 55 cents per sharefor its latest quarter, more than double the 27 cents a share loss that analysts were anticipating. Billionaire Richard Branson's space flight company also said it is evaluating a timeline for its next test flight, citing the need to analyze wear-and-tear issues for its Eve mothership.</p><p>2)&nbsp;Callaway Golf(ELY) – Callaway rallied 7.5% in premarket trading after it surged well past the 14 cents a share consensus estimate, with quarterly earnings of 62 cents per share. The golf equipment and apparel maker's revenue was also well above forecasts, with Callaway saying demand for its products has been \"unprecedented\" as the pandemic recedes.</p><p>3)&nbsp;L Brands(LB) – The retailer has decided tospin off its Victoria's Secret operationrather than sell it. L Brands will split into two separate public companies, Victoria's Secret and Bath &amp; Body Works. The move comes after bids for Victoria's Secret were short of what L Brands had expected. The plans were first reported in The New York Times' Deal book. L Brands shares fell 1.9% in premarket trading.</p><p>4)&nbsp;Palantir Technologies(PLTR) – The data analytics company matched Wall Street forecasts withquarterly profit of 4 cents per share, while revenue topped estimates. It also said it expected annual revenue growth of 30% or more through 2025. Shares dropped 6.6% in premarket action.</p><p>5)&nbsp;Hanesbrands(HBI) – The apparel maker earned 39 cents per share for its latest quarter, beating the 26 cents a share consensus estimate. Revenue came in slightly above analysts' forecasts, however its current-quarter and full-year forecast both fell short of expectations. Its stock tumbled 11.3% in the premarket. Hanesbrands also announced a three-year plan designed to boost sales and profit margins.</p><p>6)&nbsp;Perrigo(PRGO) – The maker of consumer self-care products saw its stock fall 3% in premarket trading after quarterly profit and revenue fell short of Wall Street consensus. Perrigo reaffirmed its prior full-year forecast and noted the tough comparisons to a year ago when consumers stocked up on products as the pandemic took hold.</p><p>7)&nbsp;RealReal(REAL) – The luxury goods consignment retailer matched Street forecasts with a quarterly loss of 49 cents per share, with revenue beating estimates. Research firm BTIG acknowledged the company's solid first quarter in a new analyst report, but downgraded the stock to \"neutral\" from \"buy\" based on a lack of forward catalysts. The stock tumbled 6.4% in the premarket.</p><p>8)&nbsp;Roblox(RBLX) – Roblox reported a 161% increase in quarterly bookings in the gaming platform company'sfirst report since going public. Roblox's gaming activity surged amid the pandemic as more people played games like \"Jailbreak\" and \"MeepCity,\" and spent more of the company's \"Robux\" digital currency for in-game purchases. Shares rose 2% in premarket trading.</p><p>9)&nbsp;Novavax(NVAX) – Novavax shares tumbled 11.9% in the premarket after the drugmaker pushed back its timetable for seeking Covid vaccine approvals. Novavax now said itwon't apply for regulatory approvalin the U.S., U.K. and Europe until the third quarter, and it also pushed back its timeline for full production to the fourth quarter from the third quarter.</p><p>10)&nbsp;Simon Property(SPG) – Simon Propertyreported quarterly earnings of $1.36 per share, beating consensus forecasts by 40 cents, while the mall operator's revenue was slightly above estimates. Simon also cut its full-year forecast, however, and said occupancy levels would not return to 2019 levels until 2022 at the earliest. Its shares fell 3.6% in premarket trading.</p><p>11)&nbsp;3D Systems(DDD) – 3D Systems earned 17 cents per share for its latest quarter, blowing past the 2 cents a share consensus estimate. The 3D printer maker's revenue also exceeded Wall Street predictions. 3D Systems said it improved its profit margins through expense controls. Its shares surged 9.2% in the premarket.</p><p>12)&nbsp;Norton LifeLock(NLOK) – Norton LifeLock shares rose 2.5% in premarket action after it beat estimates on both the top and bottom lines for its latest quarter. The cybersecurity company also announced a $1.5 billion increase in its share repurchase program.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-11 19:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>Reflation panic sparks global stock rout.</li><li>Tech rout is set to continue with Nasdaq 100 futures falling more than 1%.</li><li>Most of&nbsp;Blockchain stocks fell over 10%.</li><li>Tesla plunge over 6%.</li><li>FAAMG&nbsp;dipped,&nbsp;Apple fell about 3%.</li><li>Pipeline shuttered by cyberattack to restore service by end of the week.</li></ul><p>(May 11)&nbsp;Stock-index futures pointed to further losses for equities on Tuesday, with inflation worries seen keeping pressure on previously highflying tech stocks.</p><p>At 7:52 a.m. ET, Dow E-minis were fell 185 points, or 0.53%, S&amp;P 500 E-minis were down 37 points, or 0.88% and Nasdaq 100 E-minis were down 199.75 points, or 1.50%.</p><p><img src=\"https://static.tigerbbs.com/1a570ec329301f9a7665cab3c468d0b9\" tg-width=\"1242\" tg-height=\"488\" referrerpolicy=\"no-referrer\"></p><p>On Monday, a tech-led selloff sent the Nasdaq Composite&nbsp;down 2.6% to its lowest close since March 31, while the S&amp;P 500&nbsp;slumped 1%. The Dow&nbsp;gave up a gain of more than 300 points that had taken it to an all-time high above 35,000 to end the day down 34.94 points, or 0.1%.</p><p><b>What’s driving the market?</b></p><p>Further pressure on Big Tech shares appeared in store, with shares of Facebook Inc.&nbsp;Apple Inc.&nbsp;,Amazon.com Inc.&nbsp;,Netflix Inc.&nbsp;,Microsoft Corp.&nbsp;and Google parent Alphabet Inc.&nbsp;down more than 1% in premarket activity.</p><p>Apple fell about 3%,&nbsp;iPhone 12 Production Sees Over 50% Slump At Apple Supplier Foxconn's Factory In India With COVID-19.</p><p>Tesla&nbsp;shares fell nearly 4% in premarket trading as Reuters reported the electric car maker and bellwether growth play halted plans to expand its Shanghai plant into an export hub.</p><p>Most of&nbsp;Blockchain stocks fell over 10%.</p><p><img src=\"https://static.tigerbbs.com/a9ae979de807b94981438e195f617d2f\" tg-width=\"308\" tg-height=\"282\" referrerpolicy=\"no-referrer\"></p><p>“There isn’t a clear catalyst behind this purge,” said Marios Hadjikyriacos, investment analyst at XM, in a note. “It seems to be a combination of inflation fears making a comeback and some market participants moving higher along the value spectrum, cutting their exposure to anything with a stretched valuation.”</p><p>The fact that the selloff has been mostly concentrated in tech and growth stocks, however, is encouraging in terms of the overall market outlook, Hadjikyriacos said, because it indicates investors haven’t lost faith in the economic outlook but are moving away from “more speculative” positions, which could even calm some “bubble concerns, considering what is being sold.”</p><p>Investors continue to focus on the labor market after a much smaller-than-expected rise in nonfarm payrolls in March was reported on Friday.</p><p>The National Federation of Independent Business said Tuesday its monthly survey founda record 44%of small businesses said job openings went unfilled in April.</p><p>Data on U.S. March job openings is due at 10 a.m. Eastern.</p><p>Investors will also hear from several Federal Reserve officials on Tuesday, including New York Fed President John Williams, Fed Gov. Lael Brainard, San Francisco President Mary Daly, Atlanta Fed Raphael Bostic, Philadelphia Fed President Patrick Harker, and Minneapolis Fed President Neel Kashkari.</p><p><b>Stocks making the biggest moves in the premarket: Virgin Galactic, Callaway Golf, Palantir &amp; more</b></p><p>1)&nbsp;Virgin Galactic(SPCE) – Virgin Galactic shares tanked 19.9% in premarket action. The companylost 55 cents per sharefor its latest quarter, more than double the 27 cents a share loss that analysts were anticipating. Billionaire Richard Branson's space flight company also said it is evaluating a timeline for its next test flight, citing the need to analyze wear-and-tear issues for its Eve mothership.</p><p>2)&nbsp;Callaway Golf(ELY) – Callaway rallied 7.5% in premarket trading after it surged well past the 14 cents a share consensus estimate, with quarterly earnings of 62 cents per share. The golf equipment and apparel maker's revenue was also well above forecasts, with Callaway saying demand for its products has been \"unprecedented\" as the pandemic recedes.</p><p>3)&nbsp;L Brands(LB) – The retailer has decided tospin off its Victoria's Secret operationrather than sell it. L Brands will split into two separate public companies, Victoria's Secret and Bath &amp; Body Works. The move comes after bids for Victoria's Secret were short of what L Brands had expected. The plans were first reported in The New York Times' Deal book. L Brands shares fell 1.9% in premarket trading.</p><p>4)&nbsp;Palantir Technologies(PLTR) – The data analytics company matched Wall Street forecasts withquarterly profit of 4 cents per share, while revenue topped estimates. It also said it expected annual revenue growth of 30% or more through 2025. Shares dropped 6.6% in premarket action.</p><p>5)&nbsp;Hanesbrands(HBI) – The apparel maker earned 39 cents per share for its latest quarter, beating the 26 cents a share consensus estimate. Revenue came in slightly above analysts' forecasts, however its current-quarter and full-year forecast both fell short of expectations. Its stock tumbled 11.3% in the premarket. Hanesbrands also announced a three-year plan designed to boost sales and profit margins.</p><p>6)&nbsp;Perrigo(PRGO) – The maker of consumer self-care products saw its stock fall 3% in premarket trading after quarterly profit and revenue fell short of Wall Street consensus. Perrigo reaffirmed its prior full-year forecast and noted the tough comparisons to a year ago when consumers stocked up on products as the pandemic took hold.</p><p>7)&nbsp;RealReal(REAL) – The luxury goods consignment retailer matched Street forecasts with a quarterly loss of 49 cents per share, with revenue beating estimates. Research firm BTIG acknowledged the company's solid first quarter in a new analyst report, but downgraded the stock to \"neutral\" from \"buy\" based on a lack of forward catalysts. The stock tumbled 6.4% in the premarket.</p><p>8)&nbsp;Roblox(RBLX) – Roblox reported a 161% increase in quarterly bookings in the gaming platform company'sfirst report since going public. Roblox's gaming activity surged amid the pandemic as more people played games like \"Jailbreak\" and \"MeepCity,\" and spent more of the company's \"Robux\" digital currency for in-game purchases. Shares rose 2% in premarket trading.</p><p>9)&nbsp;Novavax(NVAX) – Novavax shares tumbled 11.9% in the premarket after the drugmaker pushed back its timetable for seeking Covid vaccine approvals. Novavax now said itwon't apply for regulatory approvalin the U.S., U.K. and Europe until the third quarter, and it also pushed back its timeline for full production to the fourth quarter from the third quarter.</p><p>10)&nbsp;Simon Property(SPG) – Simon Propertyreported quarterly earnings of $1.36 per share, beating consensus forecasts by 40 cents, while the mall operator's revenue was slightly above estimates. Simon also cut its full-year forecast, however, and said occupancy levels would not return to 2019 levels until 2022 at the earliest. Its shares fell 3.6% in premarket trading.</p><p>11)&nbsp;3D Systems(DDD) – 3D Systems earned 17 cents per share for its latest quarter, blowing past the 2 cents a share consensus estimate. The 3D printer maker's revenue also exceeded Wall Street predictions. 3D Systems said it improved its profit margins through expense controls. Its shares surged 9.2% in the premarket.</p><p>12)&nbsp;Norton LifeLock(NLOK) – Norton LifeLock shares rose 2.5% in premarket action after it beat estimates on both the top and bottom lines for its latest quarter. The cybersecurity company also announced a $1.5 billion increase in its share repurchase program.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101624279","content_text":"Reflation panic sparks global stock rout.Tech rout is set to continue with Nasdaq 100 futures falling more than 1%.Most of Blockchain stocks fell over 10%.Tesla plunge over 6%.FAAMG dipped, Apple fell about 3%.Pipeline shuttered by cyberattack to restore service by end of the week.(May 11) Stock-index futures pointed to further losses for equities on Tuesday, with inflation worries seen keeping pressure on previously highflying tech stocks.At 7:52 a.m. ET, Dow E-minis were fell 185 points, or 0.53%, S&P 500 E-minis were down 37 points, or 0.88% and Nasdaq 100 E-minis were down 199.75 points, or 1.50%.On Monday, a tech-led selloff sent the Nasdaq Composite down 2.6% to its lowest close since March 31, while the S&P 500 slumped 1%. The Dow gave up a gain of more than 300 points that had taken it to an all-time high above 35,000 to end the day down 34.94 points, or 0.1%.What’s driving the market?Further pressure on Big Tech shares appeared in store, with shares of Facebook Inc. Apple Inc. ,Amazon.com Inc. ,Netflix Inc. ,Microsoft Corp. and Google parent Alphabet Inc. down more than 1% in premarket activity.Apple fell about 3%, iPhone 12 Production Sees Over 50% Slump At Apple Supplier Foxconn's Factory In India With COVID-19.Tesla shares fell nearly 4% in premarket trading as Reuters reported the electric car maker and bellwether growth play halted plans to expand its Shanghai plant into an export hub.Most of Blockchain stocks fell over 10%.“There isn’t a clear catalyst behind this purge,” said Marios Hadjikyriacos, investment analyst at XM, in a note. “It seems to be a combination of inflation fears making a comeback and some market participants moving higher along the value spectrum, cutting their exposure to anything with a stretched valuation.”The fact that the selloff has been mostly concentrated in tech and growth stocks, however, is encouraging in terms of the overall market outlook, Hadjikyriacos said, because it indicates investors haven’t lost faith in the economic outlook but are moving away from “more speculative” positions, which could even calm some “bubble concerns, considering what is being sold.”Investors continue to focus on the labor market after a much smaller-than-expected rise in nonfarm payrolls in March was reported on Friday.The National Federation of Independent Business said Tuesday its monthly survey founda record 44%of small businesses said job openings went unfilled in April.Data on U.S. March job openings is due at 10 a.m. Eastern.Investors will also hear from several Federal Reserve officials on Tuesday, including New York Fed President John Williams, Fed Gov. Lael Brainard, San Francisco President Mary Daly, Atlanta Fed Raphael Bostic, Philadelphia Fed President Patrick Harker, and Minneapolis Fed President Neel Kashkari.Stocks making the biggest moves in the premarket: Virgin Galactic, Callaway Golf, Palantir & more1) Virgin Galactic(SPCE) – Virgin Galactic shares tanked 19.9% in premarket action. The companylost 55 cents per sharefor its latest quarter, more than double the 27 cents a share loss that analysts were anticipating. Billionaire Richard Branson's space flight company also said it is evaluating a timeline for its next test flight, citing the need to analyze wear-and-tear issues for its Eve mothership.2) Callaway Golf(ELY) – Callaway rallied 7.5% in premarket trading after it surged well past the 14 cents a share consensus estimate, with quarterly earnings of 62 cents per share. The golf equipment and apparel maker's revenue was also well above forecasts, with Callaway saying demand for its products has been \"unprecedented\" as the pandemic recedes.3) L Brands(LB) – The retailer has decided tospin off its Victoria's Secret operationrather than sell it. L Brands will split into two separate public companies, Victoria's Secret and Bath & Body Works. The move comes after bids for Victoria's Secret were short of what L Brands had expected. The plans were first reported in The New York Times' Deal book. L Brands shares fell 1.9% in premarket trading.4) Palantir Technologies(PLTR) – The data analytics company matched Wall Street forecasts withquarterly profit of 4 cents per share, while revenue topped estimates. It also said it expected annual revenue growth of 30% or more through 2025. Shares dropped 6.6% in premarket action.5) Hanesbrands(HBI) – The apparel maker earned 39 cents per share for its latest quarter, beating the 26 cents a share consensus estimate. Revenue came in slightly above analysts' forecasts, however its current-quarter and full-year forecast both fell short of expectations. Its stock tumbled 11.3% in the premarket. Hanesbrands also announced a three-year plan designed to boost sales and profit margins.6) Perrigo(PRGO) – The maker of consumer self-care products saw its stock fall 3% in premarket trading after quarterly profit and revenue fell short of Wall Street consensus. Perrigo reaffirmed its prior full-year forecast and noted the tough comparisons to a year ago when consumers stocked up on products as the pandemic took hold.7) RealReal(REAL) – The luxury goods consignment retailer matched Street forecasts with a quarterly loss of 49 cents per share, with revenue beating estimates. Research firm BTIG acknowledged the company's solid first quarter in a new analyst report, but downgraded the stock to \"neutral\" from \"buy\" based on a lack of forward catalysts. The stock tumbled 6.4% in the premarket.8) Roblox(RBLX) – Roblox reported a 161% increase in quarterly bookings in the gaming platform company'sfirst report since going public. Roblox's gaming activity surged amid the pandemic as more people played games like \"Jailbreak\" and \"MeepCity,\" and spent more of the company's \"Robux\" digital currency for in-game purchases. Shares rose 2% in premarket trading.9) Novavax(NVAX) – Novavax shares tumbled 11.9% in the premarket after the drugmaker pushed back its timetable for seeking Covid vaccine approvals. Novavax now said itwon't apply for regulatory approvalin the U.S., U.K. and Europe until the third quarter, and it also pushed back its timeline for full production to the fourth quarter from the third quarter.10) Simon Property(SPG) – Simon Propertyreported quarterly earnings of $1.36 per share, beating consensus forecasts by 40 cents, while the mall operator's revenue was slightly above estimates. Simon also cut its full-year forecast, however, and said occupancy levels would not return to 2019 levels until 2022 at the earliest. Its shares fell 3.6% in premarket trading.11) 3D Systems(DDD) – 3D Systems earned 17 cents per share for its latest quarter, blowing past the 2 cents a share consensus estimate. The 3D printer maker's revenue also exceeded Wall Street predictions. 3D Systems said it improved its profit margins through expense controls. Its shares surged 9.2% in the premarket.12) Norton LifeLock(NLOK) – Norton LifeLock shares rose 2.5% in premarket action after it beat estimates on both the top and bottom lines for its latest quarter. The cybersecurity company also announced a $1.5 billion increase in its share repurchase program.","news_type":1},"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}